Experts and executives in the fields of medicine, regulations, technology and public health discussed the composition of the datasets that train AI-based medical devices.
A lack of transparency surrounding the datasets that train algorithms can lead to public mistrust in AI-powered medical tools, as these devices may not have been trained using patient data that accurately represents the individuals they will be treating.
During the meeting, Center for Devices and Radiological Health Director Jeffrey Shuren, MD, noted that 562 AI-powered medical devices have received FDA emergency use authorization and pointed out that all patients should be considered when these devices are being developed and regulated.
Pat Baird, the regulatory head of global software standards at Philips, added that an algorithm that is trained on one subset of the population could be irrelevant or even harmful when applied to another group.
“To help support our patients, we need to become more familiar with them, their medical conditions, their environment, and their needs and wants to be able to better understand the potentially confounding factors that drive some of the trends in the collected data,” Baird said.
More articles on artificial intelligence:
6 recent studies exploring AI in healthcare
Mount Sinai names new dean of AI, human health: 5 things to know
VA pilots AI tool to predict COVID-19 mortality rates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.